Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EPI for the 1990s. The Expanded Programme on Immunization Team.

R J Kim-Farley1

  • 1World Health Organization, Geneva, Switzerland.

Vaccine
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The WHO-EPI initiative for the global eradication of poliomyelitis.

Biologicals : journal of the International Association of Biological Standardization·1993
Same author

Childhood immunizations.

The New England journal of medicine·1993
Same author

Studies of missed opportunities for immunization in developing and industrialized countries.

Bulletin of the World Health Organization·1993
Same author

Strategies for the global eradication of poliomyelitis by the year 2000.

The New England journal of medicine·1991
Same author

The expanded programme on immunization: a decade of progress in India.

Annals of tropical paediatrics·1989
Same author

Poliomyelitis surveillance and vaccine efficacy in Bombay, 1982-87.

Bulletin of the World Health Organization·1989
Same journal

Adverse events and vaccine administration errors following RSV vaccination: Findings from the United States VAERS database, 2023-2025.

Vaccine·2026
Same journal

Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies.

Vaccine·2026
Same journal

Human systemic and mucosal immune responses support further exploration of a Klebsiella pneumoniae protein-based vaccine.

Vaccine·2026
Same journal

Corrigendum to "Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial" [Vaccine 42(9) (2024) 2254-2259].

Vaccine·2026
Same journal

Innovative webinar-based training to support evidence-to-recommendation decision-making by national immunization technical advisory groups: multi-country experience with hexavalent vaccines.

Vaccine·2026
Same journal

Under-vaccination as a systems failure: A Monte Carlo simulation of the 2025 CDC/ACIP hepatitis B birth-dose policy shift and multi-level intervention packages, 2025-2035.

Vaccine·2026
See all related articles

This paper outlines strategies for the Expanded Programme on Immunization (EPI) in the 1990s, detailing achievements and lessons learned. It presents proposed actions and data on immunization coverage and mortality impact.

Area of Science:

  • Public Health
  • Epidemiology
  • Global Health Policy

Background:

  • The Expanded Programme on Immunization (EPI) has been crucial in global child health.
  • The 1990s presented new challenges and opportunities for immunization programs.

Purpose of the Study:

  • To review EPI achievements and lessons learned from previous decades.
  • To outline goals, policies, and strategies for EPI throughout the 1990s.
  • To propose actionable steps for the Global Advisory Group.

Main Methods:

  • Review of historical EPI data and program evaluations.
  • Analysis of immunization coverage trends.
  • Estimation of mortality and morbidity impact of immunization.

Main Results:

Related Experiment Videos

  • Documented successes and challenges of past immunization efforts.
  • Quantified impact of immunization on preventing mortality and morbidity.
  • Data presented on global immunization coverage rates.

Conclusions:

  • EPI strategies for the 1990s were endorsed by the Global Advisory Group.
  • The program aimed to build upon past successes while addressing emerging challenges.
  • Continued focus on immunization is vital for global child survival.